GB0600972D0 - Enrichment of cells - Google Patents

Enrichment of cells

Info

Publication number
GB0600972D0
GB0600972D0 GBGB0600972.4A GB0600972A GB0600972D0 GB 0600972 D0 GB0600972 D0 GB 0600972D0 GB 0600972 A GB0600972 A GB 0600972A GB 0600972 D0 GB0600972 D0 GB 0600972D0
Authority
GB
United Kingdom
Prior art keywords
enrichment
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0600972.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leeds
Original Assignee
University of Leeds
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leeds filed Critical University of Leeds
Priority to GBGB0600972.4A priority Critical patent/GB0600972D0/en
Publication of GB0600972D0 publication Critical patent/GB0600972D0/en
Priority to CNA2007800087785A priority patent/CN101400786A/zh
Priority to AU2007206750A priority patent/AU2007206750A1/en
Priority to EP07700381A priority patent/EP1979471A1/en
Priority to JP2008550832A priority patent/JP2009523438A/ja
Priority to PCT/GB2007/000107 priority patent/WO2007083093A1/en
Priority to US12/223,056 priority patent/US20100260721A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0600972.4A 2006-01-18 2006-01-18 Enrichment of cells Ceased GB0600972D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0600972.4A GB0600972D0 (en) 2006-01-18 2006-01-18 Enrichment of cells
CNA2007800087785A CN101400786A (zh) 2006-01-18 2007-01-17 细胞的富集
AU2007206750A AU2007206750A1 (en) 2006-01-18 2007-01-17 Enrichment of cells
EP07700381A EP1979471A1 (en) 2006-01-18 2007-01-17 Enrichment of cells
JP2008550832A JP2009523438A (ja) 2006-01-18 2007-01-17 細胞の富化
PCT/GB2007/000107 WO2007083093A1 (en) 2006-01-18 2007-01-17 Enrichment of cells
US12/223,056 US20100260721A1 (en) 2006-01-18 2007-01-17 Enrichment of Cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0600972.4A GB0600972D0 (en) 2006-01-18 2006-01-18 Enrichment of cells

Publications (1)

Publication Number Publication Date
GB0600972D0 true GB0600972D0 (en) 2006-03-01

Family

ID=36010490

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0600972.4A Ceased GB0600972D0 (en) 2006-01-18 2006-01-18 Enrichment of cells

Country Status (7)

Country Link
US (1) US20100260721A1 (enExample)
EP (1) EP1979471A1 (enExample)
JP (1) JP2009523438A (enExample)
CN (1) CN101400786A (enExample)
AU (1) AU2007206750A1 (enExample)
GB (1) GB0600972D0 (enExample)
WO (1) WO2007083093A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2010109698A (ru) * 2007-09-19 2011-09-27 Плуристем Лтд. (Il) Адгезивные клетки жировой ткани или плаценты и их использование в лечебных целях
JP5645197B2 (ja) * 2009-06-23 2014-12-24 学校法人日本大学 幹細胞の未分化状態を維持する新規方法
US9169464B2 (en) 2009-10-16 2015-10-27 Rutgers, The State University Of New Jersey Closed system separation of adherent bone marrow stem cells for regenerative medicine applications
SG10201408187XA (en) * 2009-12-22 2015-01-29 Agency Science Tech & Res Treatment of Bone Fracture
EP2751256A4 (en) * 2011-08-29 2015-01-28 Safeguard Cell Technology Inc ISOLATION AND THERAPEUTIC USE OF PERIVASCULAR MEDICINAL CELLS
AU2012307086B2 (en) * 2011-09-09 2016-05-26 Mesoblast, Inc. Methods for increasing osteoblastic function
CN103266081B (zh) * 2012-01-21 2015-05-13 中国人民解放军军事医学科学院附属医院 从脐带中分离培养间充质干细胞的高效方法
EP3030279B1 (en) * 2013-08-06 2020-11-04 Regenexx, LLC Bone marrow adipose portion isolation device and methods
EP2998392A1 (en) * 2014-09-16 2016-03-23 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin A population of cells for use in single-stage cell-based cartilage regeneration
TWI566774B (zh) 2014-10-06 2017-01-21 佛教慈濟醫療財團法人花蓮慈濟醫院 治療關節疾病的組成物及其方法
US10342830B2 (en) 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
US20160193254A1 (en) * 2015-01-05 2016-07-07 Gary M. Petrucci Methods and materials for treating arthritis
WO2017136557A1 (en) 2016-02-05 2017-08-10 Petrucci Gary M Methods and materials for treating nerve injuries and neurological disorders
US20180059109A1 (en) * 2016-08-31 2018-03-01 Meridigen Biotech Co., Ltd. Method of distinguishing mesenchymal stem cells and method of determining purity of mesenchymal stem cells
US11613733B2 (en) 2017-05-12 2023-03-28 Medical & Biological Laboratories Co., Ltd. Method for purifying mesenchymal stem cells to improve transplantation efficiency
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
US12391924B2 (en) 2019-02-08 2025-08-19 Regrow Biosciences Private Limited Method for mesenchymal stem cell isolation and osteoblast differentiation
US11697799B2 (en) 2019-04-15 2023-07-11 Ossium Health, Inc. System and method for extraction and cryopreservation of bone marrow
EP4181675A4 (en) 2020-07-18 2024-04-24 Ossium Health, Inc. PERMEATION OF WHOLE VERTEBRATE BODIES WITH A CRYOPRETECTIVE AGENT USING VACUUM-ASSISTED DIFFUSION
CN116583594B (zh) 2020-10-14 2025-05-23 奥瑟姆健康公司 用于骨髓的提取和低温保藏的系统和方法
WO2022133282A1 (en) 2020-12-18 2022-06-23 Ossium Health, Inc. Methods of cell therapies
KR102858598B1 (ko) 2025-01-16 2025-09-10 신종인 콜라게나제를 이용한 지방세포 이식용 조성물의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5811094A (en) * 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
CA2251983C (en) * 1996-04-19 2003-12-16 Sudhakar Kadiyala Regeneration and augmentation of bone using mesenchymal stem cells
US6835377B2 (en) * 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
US6893900B1 (en) * 1998-06-24 2005-05-17 Amkor Technology, Inc. Method of making an integrated circuit package
US7670628B2 (en) * 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
AU5723601A (en) * 2000-04-25 2001-11-07 Osiris Therapeutics Inc Joint repair using mesenchymal stem cells
US20030211602A1 (en) * 2000-04-28 2003-11-13 Anthony Atala Isolation of mesenchymal stem cells and use thereof
US20030103947A1 (en) * 2001-02-23 2003-06-05 Urlich Noth In vitro engineered cartilage constructs produced by coating biodegradable polymer with human mesenchymal stem cells
AU2003273574A1 (en) * 2002-05-31 2003-12-19 Osiris Therapeutics, Inc. Intraperitoneal delivery of genetically engineered mesenchymal stem cells
EP1641915B1 (en) * 2003-06-27 2016-07-27 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells

Also Published As

Publication number Publication date
US20100260721A1 (en) 2010-10-14
AU2007206750A1 (en) 2007-07-26
WO2007083093A1 (en) 2007-07-26
EP1979471A1 (en) 2008-10-15
JP2009523438A (ja) 2009-06-25
CN101400786A (zh) 2009-04-01

Similar Documents

Publication Publication Date Title
GB0600972D0 (en) Enrichment of cells
IL197444A0 (en) Cell culture improvements
GB2440434B (en) Fuel cells
GB2434691B (en) Fuel cell
GB2440435B (en) Fuel cells
GB0605450D0 (en) Cell co-culture
AU313071S (en) Battery
GB0605878D0 (en) Fuel cells
EP2028264A4 (en) CELL INCUBATOR
EP2069477A4 (en) CHEMICAL REPULSION OF CELLS
GB0608079D0 (en) Fuel cells
GB0705854D0 (en) Methods of construction
EP2041820A4 (en) BRENNSTOFZELLE
EP2095448A4 (en) FUEL CELL
EP1981111A4 (en) FUEL CELL
EP2063477A4 (en) FUEL CELL
GB0608054D0 (en) Production and use of regulatory t cells
GB0609926D0 (en) Electrochemical cell
GB0720790D0 (en) Manufacture of fuel
TWI369015B (en) Battery structure
GB0606671D0 (en) Cell Culture
GB0600960D0 (en) Whole cell biosensor
GB0602082D0 (en) Cells
PL380136A1 (pl) Ogniwo fotowoltaiczne
GB0610478D0 (en) Cell mobilisation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)